
Alvotech Holdings S.A
ALVO | LU
Overview
Corporate Details
- ISIN(s):
- LU2458332611
- LEI:
- 222100DCZBOWV5DZ8372
- Country:
- Luxembourg
- Address:
- 9, RUE DE BITBOURG, L-1273 LUXEMBOURG
- Website:
- https://www.alvotech.com/
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
We specialize in making biosimilars – to improve lives by expanding access to affordable biologic medicines. We are purpose-driven and passionate about what we do. We have a deep appreciation for the positive impact biologic medicines have had on health care. From insulin to vaccines to monoclonal antibody cancer therapies, biologic medicines are revolutionizing the way we treat diseases and improve patient lives. It is our aim to broaden the availability of these important biologic medicines to patients around the world by developing and manufacturing high-quality, cost-competitive biosimilars. Our commitment to the promise of biosimilars is foundational to our approach, our culture and the strong sense of purpose that inspires us to work smarter and faster towards this mission. We are driven by passion - if there is a proven biologic medicine, we believe it should be accessible to all patients in need.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Date | Filing | Language | Size | Actions |
---|---|---|---|---|
2025-07-10 10:40 |
Board/Management Change
Alvotech skipar Lindu Jónsdóttur í stöðu framkvæmdastjóra fjármálasviðs
|
Icelandic | 6.9 KB | |
2025-07-10 10:40 |
Board/Management Change
Alvotech Appoints Linda Jónsdóttir as Chief Financial Officer
|
English | 12.7 KB | |
2025-07-09 10:30 |
Regulatory News Service
Alvotech kaupir alla starfsemi Ivers-Lee Grou
|
Icelandic | 6.5 KB | |
2025-07-09 10:30 |
Regulatory News Service
Alvotech Expands its Capacity in Assembly and Packaging with the Acquisition of…
|
English | 12.7 KB | |
2025-07-04 01:02 |
Regulatory News Service
Notification for the purposes of article 13 of the Luxembourg law of 11 January…
|
English | 1.2 KB | |
2025-07-02 12:23 |
Directors' Dealings
Notification_Managers Transaction_Richard Davies
|
English | 84.6 KB | |
2025-07-02 12:21 |
Directors' Dealings
Notification_Managers Transaction_Hjörleifur Pálsson
|
English | 85.0 KB | |
2025-07-02 12:19 |
Directors' Dealings
Notification_Managers Transaction_Ann Merchant
|
English | 84.6 KB | |
2025-07-02 12:16 |
Directors' Dealings
Notification_Managers Transaction_Lisa Graver
|
English | 84.6 KB | |
2025-07-02 01:54 |
Remuneration Report
Úthlutun nýrra kauprétta og afhending áunninna hlutabréfaréttinda
|
Icelandic | 2.5 KB | |
2025-07-02 01:54 |
Directors' Dealings
Granting of Stock Options and Vesting of Restricted Share Units
|
English | 2.5 KB | |
2025-07-01 19:05 |
Declaration of Voting Results & Voting Rights Announcements
Notification of Own Shares - Alvotech
|
English | 48.3 KB | |
2025-07-01 19:00 |
Declaration of Voting Results & Voting Rights Announcements
VOTING_RIGHTS_CAPITAL_TOTAL_
|
English | 138.4 KB | |
2025-07-01 10:00 |
Regulatory News Service
Advanz Pharma semur við Alvotech um markaðssetningu í Evrópu á hliðstæðu við lí…
|
Icelandic | 6.3 KB | |
2025-07-01 10:00 |
Regulatory News Service
Alvotech and Advanz Pharma Enter into European Supply and Commercialization Agr…
|
English | 14.6 KB |
Insider Transactions
Date | Insider Name | Position | Type | Shares | Value |
---|---|---|---|---|---|
No insider transactions recorded for this company. |
Peer Companies
Company | Country | Ticker | View | |
---|---|---|---|---|
![]() |
1NKEMIA | Spain | IKM | |
![]() |
2cureX AB | Sweden | 2CUREX | |
![]() |
4SC AG | Germany | VSC | |
![]() |
Abera Bioscience AB | Sweden | ABERA | |
![]() |
ABIONYX Pharma | France | ABNX | |
|
Abliva | Sweden | ABLI | |
![]() |
AB Science | France | AB | |
![]() |
Acticor Biotech | France | ALACT | |
![]() |
Active Biotech | Sweden | ACTI | |
![]() |
AcuCort AB | Sweden | ACUC |